Fair Value Calculator Fair Value Calculator
EN DE

OCTAVE (OCTAVE) Fair Value & Analysis

IN · Market cap ₹133M

O OCTAVE OCTAVE · BSE
Price₹3.84
Fair Value₹4.52
Upside+17.7%
Quality45/100
Watch OCTAVE for free — get notified when fair value or trend changes. Watch for free
Evidence: Low Range ₹3.39 – ₹5.65

Fair value as of: Jul 5, 2026

From 7 valuation models · updated today

Share price −5.2% over the past month.

Price vs Fair Value (12 months)

₹5.90 ₹3.81 Fair Value ₹4.52 Jul 2025 Jul 2026

12‑month range ₹3.81 – ₹5.90 · fair‑value band ₹3.39 – ₹5.65 · the ₹3.84 price screens below the ₹4.52 fair value. As of Jul 5, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

OCTAVE (OCTAVE) currently trades at ₹3.84, while our model-based Fair Value estimate is ₹4.52 — implying the stock looks roughly 17.7% undervalued today. We read business quality at 45/100 (below-average quality). Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low) — always confirm before acting.

Trailing-twelve-month revenue stands at ₹2.6M. Revenue declined 85.6% year over year. It earns a return on equity of 10.2%. Net debt stands at ₹15.6M. Fundamentals as of Jul 5, 2026

Our scenario range runs from ₹3.39 (bear case) to ₹5.65 (bull case); at ₹3.84, the current price sits within that range. The share trades about 44% below its 52-week high and 12% above its 52-week low, currently below its 200-day average.

Key figures & financial health

Revenue (TTM) ₹2.6M
Revenue growth (YoY) -85.6%
Net margin 351%
Return on equity 10.2%
Free cash flow −₹5.1M FY2025
P/E ratio 14.2
More key figures
Operating margin -370%
EPS (TTM) ₹0.2700
EPS growth (YoY) -24.2%
Net debt ₹15.6M FY2025

Figures from reported company fundamentals (EODHD) · as of Jul 5, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

OCTAVE reported revenue of ₹2.6M in FY2025 versus ₹10.5M in FY2021, a compound −29.2%/yr. Reported net income was ₹9.2M in FY2025, compounding +205.4%/yr from FY2021.

Revenue −29.2%/yr
FY21 ₹10.5M
FY22 ₹15.6M
FY23 ₹16.7M
FY24 ₹7.7M
FY25 ₹2.6M
Net income +205.4%/yr
FY21 ₹106K
FY22 ₹4.2M
FY23 ₹2.3M
FY24 ₹110K
FY25 ₹9.2M

Is OCTAVE fairly valued? → Check now

🧮 Run the numbers yourself — free valuation calculators
📤 Share or link this analysis
🔗 Embed on your site (free fair-value badge)

Paste this into your site or blog — it shows the current fair value and links back here (free, and welcome):

Cite: Fair Value Calculator (2026). "OCTAVE Fair Value". https://www.fairvalue-calculator.com/stock/OCTAVE

Explore undervalued stocks

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap Stocks

Frequently asked questions

Is OCTAVE (OCTAVE) undervalued?
As of Jul 5, 2026, our model estimates a fair value of ₹4.52 versus a price of ₹3.84 — about +18% (undervalued). Model-based estimate, not financial advice.
What is the fair value of OCTAVE?
Our model-based fair value for OCTAVE is ₹4.52 (as of Jul 5, 2026), built from audited fundamentals. The current price is ₹3.84.
What is the quality score of OCTAVE?
OCTAVE has a Quality Score of 45/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.
What is the revenue of OCTAVE (OCTAVE)?
OCTAVE reported trailing-twelve-month revenue of about ₹2.6M (latest available figure, as of Jul 5, 2026).

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.